LeMaitre CFO’s Share Buy Signals Confidence in Vascular Device Growth Amid Reimbursement Shift
LeMaitre Vascular CFO’s 2,000‑share buy signals confidence in new stent grafts, AI‑driven imaging and bundled reimbursement, hinting at future upside amid a bullish market and tech‑led operational gains.
4 minutes to read